MNC Group In India Proposes Either-Or Drug-Pricing Solution
This article was originally published in PharmAsia News
Executive Summary
India's pharmaceutical industry called for the government to set drug prices based the higher of either the weighted price index or the current hike limit of 10% a year.
India's pharmaceutical industry called for the government to set drug prices based the higher of either the weighted price index or the current hike limit of 10% a year. The Organization of Pharmaceutical Producers of India, which represents multinational companies in the country, said it supported the proposed ceiling on prices, but recommended the be combined with one of the two choices. OPPI said the present cost-based pricing policy has the effect of encouraging Indian production of bulk drugs to be moved elsewhere. (Click here for more
)
"Industry Suggests Annual Capping Of Drug Prices To Be Included In Policy" - Times Of India (11/20/2012)